![PDF) Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis PDF) Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis](https://i1.rgstatic.net/publication/306245066_Assessment_of_Adverse_Events_in_Protocols_Clinical_Study_Reports_and_Published_Papers_of_Trials_of_Orlistat_A_Document_Analysis/links/57b460ad08aede8a665a4e32/largepreview.png)
PDF) Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis
![Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency | Trials | Full Text Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-018-3012-x/MediaObjects/13063_2018_3012_Fig1_HTML.png)
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency | Trials | Full Text
![Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports | BMJ Open Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/4/9/e005253/F1.large.jpg)
Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports | BMJ Open
![What you Need and When – The Key Documents in the Drug Lifecycle - Trilogy Writing & Consulting GmbH What you Need and When – The Key Documents in the Drug Lifecycle - Trilogy Writing & Consulting GmbH](https://www.trilogywriting.com/wp-content/uploads/2017/07/33.-Image-1.jpg)
What you Need and When – The Key Documents in the Drug Lifecycle - Trilogy Writing & Consulting GmbH
The European Medicines Agency Clinical Data Website Enables Insights Into Clinical Development Timelines And Strategy. - Document - Gale Academic OneFile
![Transparency of Regulatory Data across the European Medicines Agency, Health Canada, and US Food and Drug Administration | Journal of Law, Medicine & Ethics | Cambridge Core Transparency of Regulatory Data across the European Medicines Agency, Health Canada, and US Food and Drug Administration | Journal of Law, Medicine & Ethics | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20211026135733326-0888:S107311052100067X:S107311052100067X_tab3.png?pub-status=live)